Immunologic Failure Despite Suppressive Antiretroviral Therapy Is Related to Activation and Turnover of Memory CD4 Cells
Open accessThe DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Failure to normalize CD4(+) T-cell numbers despite effective antiretroviral therapy is an important problem in human immunodeficiency virus (HIV) infection. METHODS: To evaluate potential determinants of immune failure in this setting, we performed a comprehensive immunophenotypic characterization of patients with immune failure despite HIV suppression, persons who experienced CD4(+) T-cell restoration with therapy, and healthy controls. RESULTS: Profound depletion of all CD4(+) T-cell maturation subsets and depletion of naive CD8(+) T cells was found in immune failure, implying failure of T-cell production/expansion. In immune failure, both CD4(+) and CD8(+) cells were activated but only memory CD4(+) cells were cycling at increased frequency. This may be the consequence of inflammation induced by in vivo exposure to microbial products, as soluble levels of the endotoxin receptor CD14(+) and interleukin 6 were elevated in immune failure. In multivariate analyses, naive T-cell depletion, phenotypic activation (CD38(+) and HLA-DR expression), cycling of memory CD4(+) T cells, and levels of soluble CD14 (sCD14) distinguished immune failure from immune success, even when adjusted for CD4(+) T-cell nadir, age at treatment initiation, and other clinical indices. CONCLUSIONS: Immune activation that appears related to exposure to microbial elements distinguishes immune failure from immune success in treated HIV infection.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Microbial translocation is a cause of systemic immune activation in chronic HIV infection
Brenchley, J. M., Price, D. A., Schacker, T. W., Asher, T. E., Silvestri, G., Rao, S., Kazzaz, Z., Bornstein, E., Lambotte, O., Altmann, D., et al. (2006) · Nature Medicine · doi:10.1038/nm1511 · Cited by 3,559
Self-citationChanges in thymic function with age and during the treatment of HIV infection
Douek, D. C., McFarland, R. D., Keiser, P. H., Gage, E. A., Massey, J. M., Haynes, B. F., Polis, M. A., Haase, A. T., Feinberg, M. B., Sullivan#, J. L., et al. (1998) · Nature · doi:10.1038/25374 · Cited by 1,893
. Inflammatory and coagulation biomarkers and mortality in patients with HIV infection.
Kuller, L. H., Tracy, R., Belloso, W., Wit, S. D., Drummond, F., Lane, H. C., Ledergerber, B., Lundgren, J., Neuhaus, J., Nixon, D., et al. (2008) · PLoS Medicine · doi:10.1371/journal.pmed.0050203 · Cited by 1,617
Egger, M., May, M., Chêne, G., Phillips, A. N., Ledergerber, B., Dabis, F., Costagliola, D., Monforte, A. D., de Wolf, F., Reiss, P., et al. (2002) · The Lancet · doi:10.1016/s0140-6736(02)09411-4 · Cited by 1,525
Palella, F. J., Baker, R. K., Moorman, A. C., Chmiel, J. S., Wood, K. C., Brooks, J. T., & Holmberg, S. D. (2006) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/01.qai.0000233310.90484.16 · Cited by 1,350
. Plasma levels of soluble CD14 independently predict mortality in HIV infection.
Sandler, N. G., Wand, H., Roque, A., Law, M., Nason, M. C., Nixon, D. E., Pedersen, C., Ruxrungtham, K., Lewin, S. R., Emery, S., et al. (2011) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiq118 · Cited by 1,106 · cited 1×
“the Strategies for Management of Antiretroviral Therapy (SMART) study [47], sCD14 appears to be a better correlate of”
Giorgi, J. V., Hultin, L. E., McKeating, J. A., Johnson, T. D., Owens, B., Jacobson, L. P., Shih, R., Lewis, J., Wiley, D. J., Phair, J. P., et al. (1999) · The Journal of Infectious Diseases · doi:10.1086/314660 · Cited by 1,033
Hunt, P. W., Martin, J. N., Sinclair, E., Bredt, B., Hagos, E., Lampiris, H., & Deeks, S. G. (2003) · The Journal of Infectious Diseases · doi:10.1086/374786 · Cited by 852
Jiang, W., Lederman, M. M., Hunt, P., Sieg, S. F., Haley, K., Rodriguez, B., Landay, A., Martin, J., Sinclair, E., Asher, A. I., et al. (2009) · The Journal of Infectious Diseases · doi:10.1086/597476 · Cited by 591
Self-citationGiorgi, J. V., Liu, Z., Hultin, L. E., Cumberland, W. G., Hennessey, K. A., & Detels, R. (1993) · PubMed · Cited by 443
Moore, R. D., & Keruly, J. C. (2007) · Clinical Infectious Diseases · doi:10.1086/510746 · Cited by 415
Kaufmann, G. R. (2003) · Archives of Internal Medicine · doi:10.1001/archinte.163.18.2187 · Cited by 409
Kelley, C. F., Kitchen, C. M. R., Hunt, P. W., Rodriguez, B., Hecht, F. M., Kitahata, M., Crane, H. M., Willig, J., Mugavero, M., Saag, M., et al. (2009) · Clinical Infectious Diseases · doi:10.1086/597093 · Cited by 407
Self-citationLewden, C., Chêne, G., Morlat, P., Raffi, F., Dupon, M., Dellamonica, P., Pellegrin, J.-L., Katlama, C., Dabis, F., & Leport, C. (2007) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e318134257a · Cited by 402
CD4+ count and risk of non-AIDS diseases following initial treatment for HIV infection
Baker, J. V., Peng, G., Rapkin, J., Abrams, D. I., Silverberg, M. J., MacArthur, R. D., Cavert, W. P., Henry, W. K., & Neaton, J. D. (2008) · AIDS · doi:10.1097/qad.0b013e3282f7cb76 · Cited by 372
Picker, L. J., Hagen, S. I., Lum, R., Reed-Inderbitzin, E. F., Daly, L. M., Sylwester, A. W., Walker, J. M., Siess, D. C., Piatak, M., Wang, C., et al. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20041049 · Cited by 300
Marchetti, G., Bellistrì, G. M., Borghi, E., Tincati, C., Ferramosca, S., La Francesca, M., Morace, G., Gori, A., & Monforte, A. D. (2008) · AIDS · doi:10.1097/qad.0b013e3283112d29 · Cited by 297
Funderburg, N. T., Mayne, E., Sieg, S. F., Asaad, R., Jiang, W., Kalinowska, M., Luciano, A. A., Stevens, W., Rodriguez, B., Brenchley, J. M., et al. (2010) · Blood · doi:10.1182/blood-2009-03-210179 · Cited by 285
Self-citationHunt, P. W., Deeks, S. G., Rodriguez, B., Valdez, H., Shade, S. B., Abrams, D. I., Kitahata, M. M., Krone, M., Neilands, T. B., Brand, R. J., et al. (2003) · AIDS · doi:10.1097/00002030-200309050-00009 · Cited by 273
Self-citationLow CD4+ T-cell count as a major atherosclerosis risk factor in HIV-infected women and men
Kaplan, R. C., Kingsley, L. A., Gange, S. J., Benning, L., Jacobson, L. P., Lazar, J., Anastos, K., Tien, P. C., Sharrett, A. R., & Hodis, H. N. (2008) · AIDS · doi:10.1097/qad.0b013e328300581d · Cited by 265
HIV Infection Rapidly Induces and Maintains a Substantial Suppression of Thymocyte Proliferation
Dion, M.-L., Poulin, J.-F., Bordi, R., Sylvestre, M., Corsini, R., Kettaf, N., Dalloul, A., Boulassel, M.-R., Debré, P., Routy, J.-P., et al. (2004) · Immunity · doi:10.1016/j.immuni.2004.10.013 · Cited by 260
Poor CD4 T cell restoration after suppression of HIV-1 replication may reflect lower thymic function
Teixeira, L., Valdez, H., McCune, J. M., Koup, R. A., Badley, A. D., Hellerstein, M. K., Napolitano, L. A., Douek, D. C., Mbisa, G., Deeks, S., et al. (2001) · AIDS · doi:10.1097/00002030-200109280-00002 · Cited by 249
Self-citationRobbins, G. K., Spritzler, J. G., Chan, E. S., Asmuth, D. M., Gandhi, R. T., Rodriguez, B. A., Skowron, G., Skolnik, P. R., Shafer, R. W., Pollard, R. B., et al. (2009) · Clinical Infectious Diseases · doi:10.1086/595888 · Cited by 231
Self-citationValdez, H., Connick, E., Smith, K. Y., Lederman, M. M., Bosch, R. J., Kim, R. S., St. Clair, M., Kuritzkes, D. R., Kessler, H., Fox, L., et al. (2002) · AIDS · doi:10.1097/00002030-200209270-00002 · Cited by 211
Self-citationLange, C. G., Lederman, M. M., Medvik, K., Asaad, R., Wild, M., Kalayjian, R., & Valdez, H. (2003) · AIDS · doi:10.1097/00002030-200309260-00002 · Cited by 195
Self-citationLempicki, R. A., Kovacs, J. A., Baseler, M. W., Adelsberger, J. W., Dewar, R. L., Natarajan, V., Bosche, M. C., Metcalf, J. A., Stevens, R. A., Lambert, L. A., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.250472097 · Cited by 193
Abnormal activation and cytokine spectra in lymph nodes of people chronically infected with HIV-1
Biancotto, A., Grivel, J.-C., Iglehart, S. J., Vanpouille, C., Lisco, A., Sieg, S. F., Debernardo, R., Garate, K., Rodriguez, B., Margolis, L. B., et al. (2007) · Blood · doi:10.1182/blood-2006-11-055764 · Cited by 185
Self-citationAnthony, D. D., Yonkers, N. L., Post, A. B., Asaad, R., Heinzel, F. P., Lederman, M. M., Lehmann, P. V., & Valdez, H. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.8.4907 · Cited by 165
Self-citationGandhi, R. T., Spritzler, J., Chan, E., Asmuth, D. M., Rodriguez, B., Merigan, T. C., Hirsch, M. S., Shafer, R. W., Robbins, G. K., & Pollard, R. B. (2006) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/01.qai.0000226789.51992.3f · Cited by 165
Self-citationMarchetti, G. C., Gori, A., Casabianca, A., Magnani, M., Franzetti, F., Clerici, M., Perno, C. F., Monforte, A. D., Galli, M., & Meroni, L. (2006) · AIDS · doi:10.1097/01.aids.0000242819.72839.db · Cited by 165
Negredo, E., Massanella, M., Puig, J., Pérez‐Álvarez, N., Gallego-Escuredo, J. M., Villarroya, J., Villarroya, F., Moltó, J., Santos, J. R., Clotet, B., et al. (2010) · Clinical Infectious Diseases · doi:10.1086/651689 · Cited by 155
Toll-Like Receptor Ligands Induce Human T Cell Activation and Death, a Model for HIV Pathogenesis
Funderburg, N., Luciano, A. A., Jiang, W., Rodriguez, B. A., Sieg, S. F., & Lederman, M. M. (2008) · PLoS ONE · doi:10.1371/journal.pone.0001915 · Cited by 150
Self-citationSchacker, T. W., Brenchley, J. M., Beilman, G. J., Reilly, C., Pambuccian, S. E., Taylor, J. H., Skarda, D. E., Larson, M. C., Douek, D. C., & Haase, A. T. (2006) · Clinical and Vaccine Immunology · doi:10.1128/cvi.13.5.556-560.2006 · Cited by 144
Anthony, K. B., Yoder, C. P., Metcalf, J. A., DerSimonian, R., Orenstein, J. M., Stevens, R. A., Falloon, J., Polis, M. A., Lane, H. C., & Sereti, I. (2003) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/00126334-200306010-00002 · Cited by 142
Clement, L. T., Vink, P., & Bradley, G. E. (1990) · The Journal of Immunology · doi:10.4049/jimmunol.145.1.102 · Cited by 141
Rajasuriar, R., Booth, D. R., Solomon, A. E., Chua, K., Spelman, T. D., Gouillou, M., Schlub, T. E., Davenport, M. P., Crowe, S. M., Elliott, J., et al. (2010) · The Journal of Infectious Diseases · doi:10.1086/656369 · Cited by 125
Benvéniste, O., Flahault, A., Rollot, F., Elbim, C., Estaquier, J., Pédron, B., Duval, X., Dereuddre‐Bosquet, N., Clayette, P., Sterkers, G., et al. (2005) · The Journal of Infectious Diseases · doi:10.1086/429670 · Cited by 120
Schacker, T. W., Reilly, C., Beilman, G. J., Taylor, J. H., Skarda, D. E., Krason, D. A., Larson, M. C., & Haase, A. T. (2005) · AIDS · doi:10.1097/01.aids.0000194801.51422.03 · Cited by 119
Keiser, O., Taffé, P., Zwahlen, M., Battegay, M., Bernasconi, E., Weber, R. K., & Rickenbach, M. (2004) · AIDS · doi:10.1097/00002030-200409030-00013 · Cited by 89
Molina‐Pinelo, S., Vallejo, A., Diaz, L., Soriano-Sarabia, N., Ferrando‐Martínez, S., Resino, S., Muñoz‐Fernández, M. Á., & Leal, M. (2009) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkp248 · Cited by 74
Sieg, S. F., Harding, C. V., & Lederman, M. M. (2001) · Journal of Clinical Investigation · doi:10.1172/jci12685 · Cited by 71
Self-citationFernández, S., Price, P., McKinnon, E., Nolan, R. C., & French, M. A. (2006) · Clinical Immunology · doi:10.1016/j.clim.2006.04.570 · Cited by 63
Bazdar, D. A., Kalinowska, M., & Sieg, S. F. (2009) · The Journal of Infectious Diseases · doi:10.1086/597210 · Cited by 55
Self-citationSieg, S. F., Rodriguez, B. A., Asaad, R. J., Jiang, W., Bazdar, D. A., & Lederman, M. M. (2005) · The Journal of Infectious Diseases · doi:10.1086/430620 · Cited by 44
Self-citationImpaired Induction of CD27 and CD28 Predicts Naive CD4 T Cell Proliferation Defects in HIV Disease
Luciano, A. A., Lederman, M. M., Valentin-Torres, A., Bazdar, D. A., & Sieg, S. F. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.6.3543 · Cited by 29
Self-citationS-phase entry leads to cell death in circulating T cells from HIV-infected persons
Sieg, S. F., Bazdar, D. A., & Lederman, M. M. (2008) · Journal of Leukocyte Biology · doi:10.1189/jlb.0907643 · Cited by 22
Self-citationSieg, S. F., Bazdar, D. A., & Lederman, M. M. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.10.5208 · Cited by 20
Self-citation
Cited by
National Lipid Association Recommendations for Patient-Centered Management of Dyslipidemia: Part 2
Jacobson, T. A., Maki, K. C., Orringer, C. E., Jones, P. H., Kris-Etherton, P., Sikand, G., La Forge, R., Daniels, S. R., Wilson, D. P., Morris, P. B., et al. (2015) · Journal of Clinical Lipidology · doi:10.1016/j.jacl.2015.09.002 · Cited by 784
“Cellular activation With a massive depletion of CD4 cells, HIV-infected persons are left with a state of immune dysregulation manifested by low numbers of na€ıve T cells, an increase in terminally differentiated effector T cells, the generation of excessive pro-inflammatory cytokines, and altered T cell functional and…”
BackgroundCD 4+ T‐cell depletion in HIV infection: mechanisms of immunological failure
Okoye, A. A., & Picker, L. J. (2013) · Immunological Reviews · doi:10.1111/imr.12066 · Cited by 567
Microbial translocation in HIV infection: causes, consequences and treatment opportunities
Sandler, N. G., & Douek, D. C. (2012) · Nature Reviews Microbiology · doi:10.1038/nrmicro2848 · Cited by 472
Immune activation and HIV persistence: implications for curative approaches to HIV infection
Klatt, N. R., Chomont, N., Douek, D. C., & Deeks, S. G. (2013) · Immunological Reviews · doi:10.1111/imr.12065 · Cited by 435
HIV and Inflammation: Mechanisms and Consequences
Hunt, P. W. (2012) · Current HIV/AIDS Reports · doi:10.1007/s11904-012-0118-8 · Cited by 417
Metadata
- Authors
- Lederman, M. M., Calabrese, L., Funderburg, N. T., Clagett, B., Medvik, K., Bonilla, H., Gripshover, B., Salata, R. A., Taege, A., Lisgaris, M., McComsey, G. A., Kirchner, E., Baum, J., Shive, C., Asaad, R., Kalayjian, R. C., Sieg, S. F., & Rodriguez, B.
- Venue
- The Journal of Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2011-10-15
- Volume
- 204
- Issue
- 8
- Pages
- 1217-1226
- ISSN
- 0022-1899 (ISSN-L)
- 1537-6613
- OpenAlex
- W2049539466
- Cited by
- 328
- References
- 47
- FWCI
- 8.94
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.